Results 51 to 60 of about 22,320 (234)

New trends in botulinum toxin use in dermatology

Dermatology Practical & Conceptual, 2018
Background: Recent studies have highlighted new botulinum neurotoxin (BoNT) applications in the field of dermatology. Objective: To review current knowledge of BoNT use in dermatology. Methods: The literature of the last 5 years has been reviewed.
Stefania Guida, Francesca Farnetani, Steven P. Nisticò, Caterina Giorgio Mariarosaria, Graziella Babino, Giovanni Pellacani, Elisabetta Fulgione   +6 more
doaj   +1 more source

Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review

Toxins, 2021
Botulinum toxin is a superfamily of neurotoxins produced by the bacterium Clostridium Botulinum with well-established efficacy and safety profile in focal idiopathic hyperhidrosis.
Emanuela Martina, Federico Diotallevi, Giulia Radi, Anna Campanati, Annamaria Offidani   +4 more
doaj   +1 more source

High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice [PDF]

, 2011
Background: We have empirically noted that many physicians routinely request anti-phospholipid antibodies (aPL) without a correct clinical indication. The aim of this study was to evaluate retrospectively whether aPL testing at our Thrombosis Centre was ...
Barcellona D, Mameli A, Marongiu F, Vannini ML   +3 more
core   +1 more source

Disease Remission: A Scoping Review With Thematic Analysis of the Scientific Literature With Implications for Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail, Lynn Warner, Stacey T. Gray, Claire Hopkins, Peter H. Hwang, Sarah K. Wise, Katie M. Phillips, Ahmad R. Sedaghat   +7 more
wiley   +1 more source

Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case

Вопросы современной педиатрии, 2020
Background. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to ...
Tamara P. Makarova, Khakim M. Vakhitov, Dina R. Sabirova, Dinara I. Sadykova, Liliya R. Khusnutdinova, Natalya N. Firsova, Anna A. Kucheryavaya   +6 more
doaj   +1 more source

National survey of health in the tattoo industry : Observational study of 448 French tattooists [PDF]

, 2017
Peer ...
Kluger, Nicolas
core   +2 more sources

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Association of Combined Autoreactivity to Sm/RNP Common Motif and U1 RNP With Mixed Connective Tissue Disease and Systemic Lupus Erythematosus

ACR Open Rheumatology
Objective This study aimed to evaluate the clinical features in patients with suspected connective tissue disease who tested positive for anti‐Sm/RNP common motif antibody with or without associated anti‐RNP antibody.
Ruoning Ni, Aleksander Lenert, Petar Lenert   +2 more
doaj   +1 more source

Histopathology of the gut in rheumatic diseases [PDF]

, 2018
The gastrointestinal tract regulates the trafficking of macromolecules between the environment and the host through an epithelial barrier mechanism and is an important part of the immune system controlling the equilibrium between tolerance and immunity ...
Ciccia F., Ferrante A., Guggino G., Macaluso F., Rizzo A.   +4 more
core   +1 more source

Visual Hypersensitivity as a Transdiagnostic Marker of Surgical Pain Response in Arthritis and Chronic Pain Syndromes

Arthritis &Rheumatology, EarlyView.
Objective Nociplastic pain is pain primarily driven by the central nervous system and, unlike nociceptive pain conditions, is thought to be refractory to peripherally directed therapies. Nociplastic pain is also associated with hypersensitivity to painful and other sensory stimuli (such as visual stimuli). Nonpainful sensory measures have not been well
Noah Waller, Steven E. Harte, Richard E. Harris, Andrew Schrepf, Tristin Smith, Eric Ichesco, Chelsea Kaplan, Flavia Sunzini, Deeba Minhas, Wendy Marder, Sara R. Till, David A. Williams, Chad M. Brummett, Neil Basu, Sawsan As‐Sanie, Daniel J. Clauw   +15 more
wiley   +1 more source